Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $91.7219 (-2.26%) ($91.1550 - $93.6474) on Thu. Oct. 4, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.54% (three month average) | RSI | 43 | Latest Price | $91.7219(-2.26%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.1% a day on average for past five trading days. | Weekly Trend | ABBV advances 0.7% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(61%) VYM(51%) IVE(49%) SPLV(49%) IWD(48%) | Factors Impacting ABBV price | ABBV will decline at least -0.77% in a week (0% probabilities). VIXM(-14%) TLT(-14%) VXX(-13%) UUP(-11%) IFRA(-10%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.77% (StdDev 1.54%) | Hourly BBV | 0 () | Intraday Trend | -2.1% | | | |
|
Resistance Level | $91.87 | 5 Day Moving Average | $92.59(-0.94%) | 10 Day Moving Average | $92.06(-0.37%) | 20 Day Moving Average | $91.87(-0.16%) | To recent high | -5% | To recent low | 5.5% | Market Cap | $161.823b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |